APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chloroquine Drug for COVID-19

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chloroquine Drug for COVID-19 Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchChloroquine Drug for COVID-19 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chloroquine Drug for COVID-19 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chloroquine Drug for COVID-19 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chloroquine Drug for COVID-19 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chloroquine Drug for COVID-19 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chloroquine Drug for COVID-19 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chloroquine Drug for COVID-19 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chloroquine Drug for COVID-19 market include Zhongsheng Pharma, Sichuan Sunny Hope, Shanghai Pharma, Jinghua Pharmaceutical Group, North China Pharmaceutical Group, Guangzhou Baiyunshan Guanghua Pharmaceutical, Bayer, Sun Pharma and Rising Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chloroquine Drug for COVID-19 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chloroquine Drug for COVID-19 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chloroquine Drug for COVID-19 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chloroquine Drug for COVID-19 market size, projected growth trends, production technologies, key applications, and end-use industries.

Chloroquine Drug for COVID-19 Segment by Company

Zhongsheng Pharma

Sichuan Sunny Hope

Shanghai Pharma

Jinghua Pharmaceutical Group

North China Pharmaceutical Group

Guangzhou Baiyunshan Guanghua Pharmaceutical

Bayer

Sun Pharma

Rising Pharmaceutical

KPC Group

CSPC Group

Chloroquine Drug for COVID-19 Segment by Type

Tablet

Injection

Chloroquine Drug for COVID-19 Segment by Application

Mild Symptom Patient

Critically Ill Patient

Chloroquine Drug for COVID-19 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Chloroquine Drug for COVID-19 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chloroquine Drug for COVID-19 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chloroquine Drug for COVID-19 significant trends, drivers, influence factors in global and regions.

6. To analyze Chloroquine Drug for COVID-19 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Drug for COVID-19 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Drug for COVID-19 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Drug for COVID-19.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chloroquine Drug for COVID-19 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chloroquine Drug for COVID-19 industry.

Chapter 3: Detailed analysis of Chloroquine Drug for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chloroquine Drug for COVID-19 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chloroquine Drug for COVID-19 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chloroquine Drug for COVID-19 Industry Trends Table 2. Chloroquine Drug for COVID-19 Industry Drivers Table 3. Chloroquine Drug for COVID-19 Industry Opportunities and Challenges Table 4. Chloroquine Drug for COVID-19 Industry Restraints Table 5. Global Chloroquine Drug for COVID-19 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chloroquine Drug for COVID-19 Revenue Share by Company (2021-2026) Table 7. Global Chloroquine Drug for COVID-19 Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Chloroquine Drug for COVID-19 Sales Volume Share by Company (2021-2026) Table 9. Global Chloroquine Drug for COVID-19 Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Chloroquine Drug for COVID-19 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chloroquine Drug for COVID-19 Key Company Manufacturing Base & Headquarters Table 12. Global Chloroquine Drug for COVID-19 Company, Product Type & Application Table 13. Global Chloroquine Drug for COVID-19 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chloroquine Drug for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Injection Table 19. Global Chloroquine Drug for COVID-19 Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Chloroquine Drug for COVID-19 Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Chloroquine Drug for COVID-19 Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Chloroquine Drug for COVID-19 Sales Volume Share by Type (2021-2026) Table 23. Global Chloroquine Drug for COVID-19 Sales Volume Share by Type (2027-2032) Table 24. Global Chloroquine Drug for COVID-19 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Chloroquine Drug for COVID-19 Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Chloroquine Drug for COVID-19 Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Chloroquine Drug for COVID-19 Sales Value Share by Type (2021-2026) Table 28. Global Chloroquine Drug for COVID-19 Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Mild Symptom Patient Table 30. Significant Companies of Critically Ill Patient Table 31. Global Chloroquine Drug for COVID-19 Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Chloroquine Drug for COVID-19 Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Chloroquine Drug for COVID-19 Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Chloroquine Drug for COVID-19 Sales Volume Share by Application (2021-2026) Table 35. Global Chloroquine Drug for COVID-19 Sales Volume Share by Application (2027-2032) Table 36. Global Chloroquine Drug for COVID-19 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Chloroquine Drug for COVID-19 Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Chloroquine Drug for COVID-19 Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Chloroquine Drug for COVID-19 Sales Value Share by Application (2021-2026) Table 40. Global Chloroquine Drug for COVID-19 Sales Value Share by Application (2027-2032) Table 41. Global Chloroquine Drug for COVID-19 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Chloroquine Drug for COVID-19 Sales by Region (2021-2026) & (Tons) Table 43. Global Chloroquine Drug for COVID-19 Sales Market Share by Region (2021-2026) Table 44. Global Chloroquine Drug for COVID-19 Sales by Region (2027-2032) & (Tons) Table 45. Global Chloroquine Drug for COVID-19 Sales Market Share by Region (2027-2032) Table 46. Global Chloroquine Drug for COVID-19 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Chloroquine Drug for COVID-19 Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Chloroquine Drug for COVID-19 Sales Value Share by Region (2021-2026) Table 49. Global Chloroquine Drug for COVID-19 Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Chloroquine Drug for COVID-19 Sales Value Share by Region (2027-2032) Table 51. Global Chloroquine Drug for COVID-19 Market Average Price (US$/Ton) by Region (2021-2026) Table 52. Global Chloroquine Drug for COVID-19 Market Average Price (US$/Ton) by Region (2027-2032) Table 53. Global Chloroquine Drug for COVID-19 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Chloroquine Drug for COVID-19 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Chloroquine Drug for COVID-19 Sales by Country (2021-2026) & (Tons) Table 56. Global Chloroquine Drug for COVID-19 Sales Market Share by Country (2021-2026) Table 57. Global Chloroquine Drug for COVID-19 Sales by Country (2027-2032) & (Tons) Table 58. Global Chloroquine Drug for COVID-19 Sales Market Share by Country (2027-2032) Table 59. Global Chloroquine Drug for COVID-19 Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Chloroquine Drug for COVID-19 Sales Value Market Share by Country (2021-2026) Table 61. Global Chloroquine Drug for COVID-19 Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Chloroquine Drug for COVID-19 Sales Value Market Share by Country (2027-2032) Table 63. Zhongsheng Pharma Company Information Table 64. Zhongsheng Pharma Business Overview Table 65. Zhongsheng Pharma Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Zhongsheng Pharma Chloroquine Drug for COVID-19 Product Portfolio Table 67. Zhongsheng Pharma Recent Development Table 68. Sichuan Sunny Hope Company Information Table 69. Sichuan Sunny Hope Business Overview Table 70. Sichuan Sunny Hope Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Sichuan Sunny Hope Chloroquine Drug for COVID-19 Product Portfolio Table 72. Sichuan Sunny Hope Recent Development Table 73. Shanghai Pharma Company Information Table 74. Shanghai Pharma Business Overview Table 75. Shanghai Pharma Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Shanghai Pharma Chloroquine Drug for COVID-19 Product Portfolio Table 77. Shanghai Pharma Recent Development Table 78. Jinghua Pharmaceutical Group Company Information Table 79. Jinghua Pharmaceutical Group Business Overview Table 80. Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio Table 82. Jinghua Pharmaceutical Group Recent Development Table 83. North China Pharmaceutical Group Company Information Table 84. North China Pharmaceutical Group Business Overview Table 85. North China Pharmaceutical Group Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. North China Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio Table 87. North China Pharmaceutical Group Recent Development Table 88. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 89. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 90. Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio Table 92. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Bayer Chloroquine Drug for COVID-19 Product Portfolio Table 97. Bayer Recent Development Table 98. Sun Pharma Company Information Table 99. Sun Pharma Business Overview Table 100. Sun Pharma Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Sun Pharma Chloroquine Drug for COVID-19 Product Portfolio Table 102. Sun Pharma Recent Development Table 103. Rising Pharmaceutical Company Information Table 104. Rising Pharmaceutical Business Overview Table 105. Rising Pharmaceutical Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Rising Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio Table 107. Rising Pharmaceutical Recent Development Table 108. KPC Group Company Information Table 109. KPC Group Business Overview Table 110. KPC Group Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. KPC Group Chloroquine Drug for COVID-19 Product Portfolio Table 112. KPC Group Recent Development Table 113. CSPC Group Company Information Table 114. CSPC Group Business Overview Table 115. CSPC Group Chloroquine Drug for COVID-19 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. CSPC Group Chloroquine Drug for COVID-19 Product Portfolio Table 117. CSPC Group Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Chloroquine Drug for COVID-19 Distributors List Table 121. Chloroquine Drug for COVID-19 Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Chloroquine Drug for COVID-19 Product Image Figure 2. Global Chloroquine Drug for COVID-19 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chloroquine Drug for COVID-19 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chloroquine Drug for COVID-19 Sales (2021-2032) & (Tons) Figure 5. Global Chloroquine Drug for COVID-19 Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Chloroquine Drug for COVID-19 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Injection Image Figure 11. Global Chloroquine Drug for COVID-19 Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Chloroquine Drug for COVID-19 Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Chloroquine Drug for COVID-19 Sales Volume Share by Type (2021-2032) Figure 14. Global Chloroquine Drug for COVID-19 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Chloroquine Drug for COVID-19 Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Chloroquine Drug for COVID-19 Sales Value Share by Type (2021-2032) Figure 17. Mild Symptom Patient Image Figure 18. Critically Ill Patient Image Figure 19. Global Chloroquine Drug for COVID-19 Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Chloroquine Drug for COVID-19 Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Chloroquine Drug for COVID-19 Sales Volume Share by Application (2021-2032) Figure 22. Global Chloroquine Drug for COVID-19 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Chloroquine Drug for COVID-19 Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Chloroquine Drug for COVID-19 Sales Value Share by Application (2021-2032) Figure 25. Global Chloroquine Drug for COVID-19 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Chloroquine Drug for COVID-19 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Chloroquine Drug for COVID-19 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Chloroquine Drug for COVID-19 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Chloroquine Drug for COVID-19 Sales Value (2021-2032) & (US$ Million) Figure 30. North America Chloroquine Drug for COVID-19 Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Chloroquine Drug for COVID-19 Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Chloroquine Drug for COVID-19 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Chloroquine Drug for COVID-19 Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Chloroquine Drug for COVID-19 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Chloroquine Drug for COVID-19 Sales Value (2021-2032) & (US$ Million) Figure 36. South America Chloroquine Drug for COVID-19 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Chloroquine Drug for COVID-19 Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Chloroquine Drug for COVID-19 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Chloroquine Drug for COVID-19 Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Chloroquine Drug for COVID-19 Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Mild Symptom Patient
  • Critically Ill Patient
Companies covered
  • Zhongsheng Pharma
  • Sichuan Sunny Hope
  • Shanghai Pharma
  • Jinghua Pharmaceutical Group
  • North China Pharmaceutical Group
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Bayer
  • Sun Pharma
  • Rising Pharmaceutical
  • KPC Group
  • CSPC Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chloroquine Drug for COVID-19 Sales Value (2021-2032)
  4. 1.2.2 Global Chloroquine Drug for COVID-19 Sales Volume (2021-2032)
  5. 1.2.3 Global Chloroquine Drug for COVID-19 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chloroquine Drug for COVID-19 Market Dynamics
  1. 2.1 Chloroquine Drug for COVID-19 Industry Trends
  2. 2.2 Chloroquine Drug for COVID-19 Industry Drivers
  3. 2.3 Chloroquine Drug for COVID-19 Industry Opportunities and Challenges
  4. 2.4 Chloroquine Drug for COVID-19 Industry Restraints
3 Chloroquine Drug for COVID-19 Market by Company
  1. 3.1 Global Chloroquine Drug for COVID-19 Company Revenue Ranking in 2025
  2. 3.2 Global Chloroquine Drug for COVID-19 Revenue by Company (2021-2026)
  3. 3.3 Global Chloroquine Drug for COVID-19 Sales Volume by Company (2021-2026)
  4. 3.4 Global Chloroquine Drug for COVID-19 Average Price by Company (2021-2026)
  5. 3.5 Global Chloroquine Drug for COVID-19 Company Ranking (2024-2026)
  6. 3.6 Global Chloroquine Drug for COVID-19 Company Manufacturing Base and Headquarters
  7. 3.7 Global Chloroquine Drug for COVID-19 Company Product Type and Application
  8. 3.8 Global Chloroquine Drug for COVID-19 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chloroquine Drug for COVID-19 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chloroquine Drug for COVID-19 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chloroquine Drug for COVID-19 Market by Type
  1. 4.1 Chloroquine Drug for COVID-19 Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Injection
  4. 4.2 Global Chloroquine Drug for COVID-19 Sales Volume by Type
  5. 4.2.1 Global Chloroquine Drug for COVID-19 Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chloroquine Drug for COVID-19 Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Chloroquine Drug for COVID-19 Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Chloroquine Drug for COVID-19 Sales Value by Type
  9. 4.3.1 Global Chloroquine Drug for COVID-19 Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Chloroquine Drug for COVID-19 Sales Value by Type (2021-2032)
  11. 4.3.3 Global Chloroquine Drug for COVID-19 Sales Value Share by Type (2021-2032)
5 Chloroquine Drug for COVID-19 Market by Application
  1. 5.1 Chloroquine Drug for COVID-19 Application Introduction
  2. 5.1.1 Mild Symptom Patient
  3. 5.1.2 Critically Ill Patient
  4. 5.2 Global Chloroquine Drug for COVID-19 Sales Volume by Application
  5. 5.2.1 Global Chloroquine Drug for COVID-19 Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chloroquine Drug for COVID-19 Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Chloroquine Drug for COVID-19 Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Chloroquine Drug for COVID-19 Sales Value by Application
  9. 5.3.1 Global Chloroquine Drug for COVID-19 Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chloroquine Drug for COVID-19 Sales Value by Application (2021-2032)
  11. 5.3.3 Global Chloroquine Drug for COVID-19 Sales Value Share by Application (2021-2032)
6 Chloroquine Drug for COVID-19 Regional Sales and Value Analysis
  1. 6.1 Global Chloroquine Drug for COVID-19 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chloroquine Drug for COVID-19 Sales by Region (2021-2032)
  3. 6.2.1 Global Chloroquine Drug for COVID-19 Sales by Region: 2021-2026
  4. 6.2.2 Global Chloroquine Drug for COVID-19 Sales by Region (2027-2032)
  5. 6.3 Global Chloroquine Drug for COVID-19 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chloroquine Drug for COVID-19 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chloroquine Drug for COVID-19 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chloroquine Drug for COVID-19 Sales Value by Region (2027-2032)
  9. 6.5 Global Chloroquine Drug for COVID-19 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chloroquine Drug for COVID-19 Sales Value (2021-2032)
  12. 6.6.2 North America Chloroquine Drug for COVID-19 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chloroquine Drug for COVID-19 Sales Value (2021-2032)
  15. 6.7.2 Europe Chloroquine Drug for COVID-19 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chloroquine Drug for COVID-19 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chloroquine Drug for COVID-19 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chloroquine Drug for COVID-19 Sales Value (2021-2032)
  21. 6.9.2 South America Chloroquine Drug for COVID-19 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chloroquine Drug for COVID-19 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chloroquine Drug for COVID-19 Sales Value Share by Country, 2025 VS 2032
7 Chloroquine Drug for COVID-19 Country-level Sales and Value Analysis
  1. 7.1 Global Chloroquine Drug for COVID-19 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chloroquine Drug for COVID-19 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
  4. 7.3.1 Global Chloroquine Drug for COVID-19 Sales by Country (2021-2026)
  5. 7.3.2 Global Chloroquine Drug for COVID-19 Sales by Country (2027-2032)
  6. 7.4 Global Chloroquine Drug for COVID-19 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chloroquine Drug for COVID-19 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chloroquine Drug for COVID-19 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chloroquine Drug for COVID-19 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chloroquine Drug for COVID-19 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chloroquine Drug for COVID-19 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongsheng Pharma
  2. 8.1.1 Zhongsheng Pharma Company Information
  3. 8.1.2 Zhongsheng Pharma Business Overview
  4. 8.1.3 Zhongsheng Pharma Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhongsheng Pharma Chloroquine Drug for COVID-19 Product Portfolio
  6. 8.1.5 Zhongsheng Pharma Recent Developments
  7. 8.2 Sichuan Sunny Hope
  8. 8.2.1 Sichuan Sunny Hope Company Information
  9. 8.2.2 Sichuan Sunny Hope Business Overview
  10. 8.2.3 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Product Portfolio
  12. 8.2.5 Sichuan Sunny Hope Recent Developments
  13. 8.3 Shanghai Pharma
  14. 8.3.1 Shanghai Pharma Company Information
  15. 8.3.2 Shanghai Pharma Business Overview
  16. 8.3.3 Shanghai Pharma Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Pharma Chloroquine Drug for COVID-19 Product Portfolio
  18. 8.3.5 Shanghai Pharma Recent Developments
  19. 8.4 Jinghua Pharmaceutical Group
  20. 8.4.1 Jinghua Pharmaceutical Group Company Information
  21. 8.4.2 Jinghua Pharmaceutical Group Business Overview
  22. 8.4.3 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
  24. 8.4.5 Jinghua Pharmaceutical Group Recent Developments
  25. 8.5 North China Pharmaceutical Group
  26. 8.5.1 North China Pharmaceutical Group Company Information
  27. 8.5.2 North China Pharmaceutical Group Business Overview
  28. 8.5.3 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
  30. 8.5.5 North China Pharmaceutical Group Recent Developments
  31. 8.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
  32. 8.6.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  33. 8.6.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  34. 8.6.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
  36. 8.6.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Chloroquine Drug for COVID-19 Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Chloroquine Drug for COVID-19 Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Rising Pharmaceutical
  50. 8.9.1 Rising Pharmaceutical Company Information
  51. 8.9.2 Rising Pharmaceutical Business Overview
  52. 8.9.3 Rising Pharmaceutical Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Rising Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
  54. 8.9.5 Rising Pharmaceutical Recent Developments
  55. 8.10 KPC Group
  56. 8.10.1 KPC Group Company Information
  57. 8.10.2 KPC Group Business Overview
  58. 8.10.3 KPC Group Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 KPC Group Chloroquine Drug for COVID-19 Product Portfolio
  60. 8.10.5 KPC Group Recent Developments
  61. 8.11 CSPC Group
  62. 8.11.1 CSPC Group Company Information
  63. 8.11.2 CSPC Group Business Overview
  64. 8.11.3 CSPC Group Chloroquine Drug for COVID-19 Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CSPC Group Chloroquine Drug for COVID-19 Product Portfolio
  66. 8.11.5 CSPC Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chloroquine Drug for COVID-19 Value Chain Analysis
  2. 9.1.1 Chloroquine Drug for COVID-19 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chloroquine Drug for COVID-19 Sales Mode & Process
  6. 9.2 Chloroquine Drug for COVID-19 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chloroquine Drug for COVID-19 Distributors
  9. 9.2.3 Chloroquine Drug for COVID-19 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst